[Mono-bugs] STOCK MARKET ALERT: PDPR exceeding its projections for Q1 of 2004

[Daisy Moore]

----35486681768847521
Content-Type: text/plain;
Content-Transfer-Encoding: quoted-printable

OTC FIRST ALERT -  PDPR Pediatric Fittings to be Funded by Panhandle Lions=
 Club of Texas and Medicaid

Symbol: PDPR
Market: PK
Sector: $100 million Infant-Pediatric Prosthetics Market

BREAKING NEWS: HOUSTON, Jan 29, 2004 (BUSINESS WIRE) -- Pediatric Prosthet=
ics 
Inc. (OTC:PDPR) is pleased to announce that the Company is exceeding its 
projections for the first quarter of 2004.


BREAKING NEWS:  HOUSTON, Jan 26, 2004 (BUSINESS WIRE) PDPR announces that =

The Panhandle Lions Clubs of Texas has funded two arms for a beautiful you=
ng 
girl in their community. She had no hands, but now she has two hands to ai=
d 
her in living a more independent life.

>> Medicaid and other insurance companies will be funding more than 70 inf=
ant 
prosthetic fittings this year, which will create annual positive revenue f=
or 
PDPR of nearly $1.5 million 

1. Of these 70 infant fittings, each year each child will need a re-socket=
 
re-build generating $630,000 annually.  
2. Every third year these same 70 fittings will need a completely new 
prosthetic limb again generating $1.5 million for PDPR.
3. The total revenue generated from these initial 70 fittings, from infanc=
y 
to adulthood, is approximately $14 million!

>> The Panhandle Lions Clubs of Texas has teamed up with PDPR to fund Texa=
s 
children in need of a infant prosthetic fittings and are uninsured.  


BREAKING NEWS:  LAKE HARMONY, PA, Jan. 23, 2004 (MARKET WIRE via COMTEX) -=
- 
IOCircuit.com reiterates a Buy rating and announces the completing of 
build-out of the pediatric lab/clinic at 12926 Willowchase, Houston. Feb. =
1, 
2004 is the planned grand opening



The national prosthetics market is estimated at nearly $2 billion annually=
 
and is extremely fragmented.   PDPR's infant prosthetic segment of this 
market is estimated at $100 million 
    
>> Jim Furey of Lehman Brothers says, "You want to own small stocks versus=
 
large stocks when economic growth is accelerating, which is exactly the 
period we're in now."
   
PDPR's a NEW Public company that's primed to dominate this $100 million 
Infant-Pediatric Prosthetics segment.  
   
In its segment, PDPR's hope is to repeat the success Hanger, Inc.  Hanger,=
 
Inc. currently trades on the (NYSE "HGR"), and has a market cap of approx.=
 
$366 million

>> Currently PDPR is the only company focusing on the unique needs of the =

infant-pediatric prosthetics segment



PEDIATRIC PROSTHETICS MARKET

Children ages 0 to 14 comprise $100 million of the total $2 billion nation=
al 
prosthetic market.  The vast majority of this pediatric prosthetic market =

derives from infants born with a limb loss.

This infant prosthetic segment allows PDPR to generate a consistent revenu=
e 
stream from childhood to adulthood.  Revenue from infancy to adulthood is =

anticipated to be over $200,000, with adults spend an additional $200,000.=
  


Medicaid and other insurance companies will be funding more than 70 infant=
 
prosthetic fittings this year, which will create annual positive revenue f=
or 
PDPR of nearly $1.5 million 

1. Of these 70 infant fittings, each year each child will need a re-socket=
 
re-build generating $630,000 annually.  

2. Every third year these same 70 fittings will need a completely new 
prosthetic limb again generating $1.5 million for PDPR.

3. The total revenue generated from these initial 70 fittings, from infanc=
y 
to adulthood, is approximately $14 million!

This "annuity effect" will compound earnings each year and enable PDPR to =

enjoy stable growth and profitability over the short and long term.



PDPR MANAGEMENT TEAM

The management team of PDPR is nationally recognized as the leading 
prosthetists in the infant-pediatric prosthetics field.  PDRP's management=
's 
been featured in, "Orthotics & Prosthetics Business News", written up in 
"Life Magazine", and some of the fitted children have appeared on national=
 
TV shows, including  "Good Morning America", "Maury Povich", "Phil Donahue=
", 
and "20-20".



FINAL CONSIDERATIONS

PDPR developed a strong niche in the nearly $100 million infant-pediatric =

need.  

>> PDPR is the only company specializing in the national needs of the 
Infant-Pediatric Prosthetics segment.

>> Focusing on its segment will allow PDPR to generate a consistent revenu=
e 
stream from childhood to adulthood.  The "annuity effect" will compound 
earnings each year and enable PDPR to enjoy stable growth and profitabilit=
y 
over the short and long term.




Receive First Notice on Companies like PDPR (first_alert@otcfirstalert.com=
)






The information herein is for information purposes only and should not be =

construed as an offer or solicitation of an offer to buy or to sell 
securities. This assembled information is based on information supplied by=
 
the company, press releases, SEC filings, or from other sources believed t=
o 
be reliable, but no representation, expressed or implied, is made as to it=
s 
accuracy, completeness or correctness. The data contained herein is subjec=
t 
to change without notice. Small-cap companies, micro-cap companies, penny =

stocks and/or thinly traded securities are inherently risky and volatile; =

therefore the risk of losing some or all should be calculated. Please alwa=
ys 
do your own due diligence and consult a financial advisor. OTCFirstAlert 
accepts no liability for any losses arising from an investor's reliance on=
 
or use of this report. Affiliates of OTCFirstAlert have been hired by a 
third party and are to one million trading shares for the construction and=
 
dissemination of this information. OTCFirstAlert and its affiliates, 
officers, directors, members and employees may hold, buy or sell common 
shares of profiled companies in the open market without notice. On technic=
al 
analysis may from time to time cause the target price to fluctuate without=
 
notice. Certain information included herein is forward-looking within the =

meaning of the Private Securities Litigation Reform Act of 1995, including=
, 
but not limited to, statements concerning manufacturing, marketing, growth=
, 
and expansion. Such forward-looking information involves important risks a=
nd 
uncertainties that could affect actual results and cause them to differ 
materially from expectations expressed herein. 

6 Eftute Ave
Kingston 10
Jamaca WI

To be removed from our list, please go to http://www.ministration.biz/remo=
ve.php

----35486681768847521--